As of 2025-08-02, the Fair Value of Innovent Biologics Inc (1801.HK) is -0.39 HKD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 93.00 HKD, the upside of Innovent Biologics Inc is -100.42%.
With the market price of 93.00 HKD and our fair value calculation, Innovent Biologics Inc (1801.HK) is not a good investment. Investing in 1801.HK stocks now will result in a potential loss of 100.42%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -998.42 | -2,728.76 | -2,179.27 | -1,027.91 | -94.63 | -1,405.80 |
| YoY growth | 41.95% | -173.31% | 20.14% | 52.83% | 90.79% | 6.48% |
| Market Cap (mil) | 158,976.98 |
| P/E | |
| Forward P/E |
| EPS | -0.06 |
| Avg earnings growth rate | 6.48% |
| TTM earnings | -94.63 |